Journal
CURRENT PSYCHIATRY REPORTS
Volume 13, Issue 6, Pages 437-442Publisher
SPRINGER
DOI: 10.1007/s11920-011-0234-y
Keywords
Alzheimer's disease; Clinical trials; Neurodegenerative diseases; Biomarkers; Amyloid beta-protein; Tau protein; Cerebrospinal fluid; Amyloid imaging; MRI; Drug development; ADAS-cog; Apolipoprotein genotype; Presenilin mutations; APP mutations; Frontotemporal dementia; Progranulin; Isoprostanes